离散遗传亚型与肿瘤微环境特征与外周T细胞淋巴瘤预后相关
该研究对129例外周T细胞淋巴瘤(PTCL)患者行全外显子测序和转录组分析,识别出C1、C2、C3三个遗传亚型,并将肿瘤微环境(TME)分为TME1、TME2、TME3。与C1相比,C2和C3生存显著更差;TME2与更短生存相关且在C2中更常见。
要点
- C2以抑癌基因缺失和染色体不稳定为特征,C1和C3共享TFH相关基因组改变。
- 与C1相比,C2生存显著更差(HR 2.52;95% CI 1.37-4.63),C3亦更差(HR 2.14;95% CI 1.17-3.89)。
- TME2与更短生存相关(HR 3.4;95% CI 1.6-7.5),且在C2中占比64.3%高于C1的7.7%。
核心结论
- PTCL中遗传亚型与TME特征存在显著关联,对临床预后有重要意义。
研究设计与样本
- 研究纳入129例PTCL患者,进行全外显子测序和bulk RNA测序,采用CIBERSORTx估计免疫细胞组分比例。
主要发现
- 识别出三个遗传亚型C1、C2、C3;C2以抑癌基因缺失和染色体不稳定为特征,C1和C3共享TFH相关基因组改变,C3还有高频率IDH2突变和5号染色体获得。
- 与C1相比,C2生存显著更差(HR 2.52;95% CI 1.37-4.63),C3生存亦显著更差(HR 2.14;95% CI 1.17-3.89)。
- TME分为TME1(B细胞和TFH细胞增多)、TME2(巨噬细胞)、TME3(活化肥大细胞);TME2与更短生存相关(HR 3.4;95% CI 1.6-7.5)。
- TME2在C2中占64.3%,高于C1的7.7%;C1中TME3特征占80.8%,高于C2的28.6%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Peripheral T-cell lymphoma (PTCL) exhibits a diverse clinical spectrum, necessitating methods to categorize patients based on genomic abnormalities or tumor microenvironment (TME) profiles. We conducted an integrative multiomics study in 129 PTCL patients, performing whole-exome sequencing and identifying three genetic subtypes: C1, C2, and C3. C2 was characterized by loss of tumor suppressor genes and chromosomal instability, while C1 and C3 shared T follicular helper (TFH)-related genomic alterations, with C3 also showing a high incidence of IDH2 mutations and chromosome 5 gain. Compared to C1, survival was significantly worse in C2 (HR 2.52; 95% CI, 1.37-4.63) and C3 (HR 2.14; 95% CI, 1.17-3.89). We also estimated the proportions of immune cell fractions from the bulk RNA sequencing data using CIBERSORTx and classified TME signatures into the following hierarchical clusters: TME1 (characterized by increased B and TFH cells), TME2 (macrophages), and TME3 (activated mast cells). TME2 was associated with shorter survival (HR 3.4; 95% CI, 1.6-7.5) and was more frequent in C2 (64.3%) than in C1 (7.7%), whereas C1 had more TME3 signatures (80.8% vs. 28.6%). These findings highlight a significant relationship between genetic subtypes and TME signatures in PTCL, with important implications for clinical prognosis.
引用
- Suehara Y, Sakamoto K, Fujisawa M, et al. Discrete genetic subtypes and tumor microenvironment signatures correlate with peripheral T-cell lymphoma outcomes. Leukemia. 2025. PMID: 40164718. doi:10.1038/s41375-025-02563-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。